Research

INFINITE promotes a transversal and collaborative approach to research within its research groups.

Our work is regularly published in leading international scientific journals, with strong impact factors. Over the last 5 years, INFINITE researchers have written more than 1,500 scientific publications. These publications reflect the diversity of our specialists and the transversal nature of their work.

Our publications fall into several clinical fields: gastroenterology, hepatology, internal medicine, microbiology, immunology, transplants, respiratory and nutrition.

Each research group shares their progress and challenges during weekly and monthly meetings held in INFINITE. This approach multiplies the perspectives and spurs the creativity of the teams.

INFINITE conducts excellent translational research based on large cohorts of adult and pediatric patients (IBD, liver diseases, multiple sclerosis, eosinophilia, cystic fibrosis and bone marrow transplant). Substantial contributions have been made to national and international therapeutic studies, most particularly in IBD, alcoholic cirrhosis and multiple sclerosis, published in journals with a high impact factor. Significant contributions have also been made in epidemiology, based on the EPIMAD registry, the world’s largest population-based registry for IBDs.

Key Figures

  • 4.5 million euros worth of national and international research projects supported over 4 years
  • 58 clinical trials coordinated or conducted
  • 8 international congresses organized
  • 100 invited lectures
  • >1,500 publications over the last 5 years
  • 24 projects conducted with industrials for a total budget of €1.3 million
  • 20 Ph.D. theses defended in 3 years
  • 27 Ph.D. in progress
  • 23 filed patents
  • 5 molecules in phase I or II of development